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Common regulatory control of CTP synthase 
enzyme activity and filament formation
Chalongrat Noreea,b,*, Elena Monforta,*, Andrew K. Shiauc, and James E. Wilhelma
aSection on Cell and Developmental Biology, University of California, San Diego, La Jolla, CA 92093; bInstitute of 
Molecular Biosciences, Mahidol University, Salaya, Nakhon Pathom 73170, Thailand; cSmall Molecule Discovery 
Program, Ludwig Institute for Cancer Research, La Jolla, CA 92093
ABSTRACT The ability of enzymes to assemble into visible supramolecular complexes is a 
widespread phenomenon. Such complexes have been hypothesized to play a number of 
roles; however, little is known about how the regulation of enzyme activity is coupled to the 
assembly/disassembly of these cellular structures. CTP synthase is an ideal model system for 
addressing this question because its activity is regulated via multiple mechanisms and its fila-
ment-forming ability is evolutionarily conserved. Our structure–function studies of CTP syn-
thase in Saccharomyces cerevisiae reveal that destabilization of the active tetrameric form of 
the enzyme increases filament formation, suggesting that the filaments comprise inactive 
CTP synthase dimers. Furthermore, the sites responsible for feedback inhibition and allos-
teric activation control filament length, implying that multiple regions of the enzyme can in-
fluence filament structure. In contrast, blocking catalysis without disrupting the regulatory 
sites of the enzyme does not affect filament formation or length. Together our results argue 
that the regulatory sites that control CTP synthase function, but not enzymatic activity per se, 
are critical for controlling filament assembly. We predict that the ability of enzymes to form 
supramolecular structures in general is closely coupled to the mechanisms that regulate their 
activity.
INTRODUCTION
The past several years have seen an explosion in the identification 
of novel intracellular structures (Sheth and Parker, 2003; Campbell 
et al., 2005; An et al., 2008; Narayanaswamy et al., 2009; Ingerson-
Mahar et al., 2010; Liu, 2010; Noree et al., 2010). Although the 
macromolecular components and putative functions of these large 
cytoplasmic structures are diverse, they share a common theme: 
each class of structure is formed from enzymes that act in a specific 
biochemical or regulatory pathway. For example, processing bodies 
are visible supramolecular complexes comprising mRNAs and 
many of the enzymes that regulate their translation and stability 
(Sheth and Parker, 2003). Similarly, purinosomes assemble from a 
subset of enzymes in the de novo purine biosynthetic pathway in 
response to purine deprivation in order to accelerate flux through 
the pathway via substrate channeling (An et al., 2008, 2010a,b). 
Strikingly, recent visual screens of the yeast green fluorescent pro-
tein (GFP) strain collection reveal that multiple metabolic enzymes 
self-assemble into filaments, arguing that this mode of regulation 
could play a role in the control of many biosynthetic pathways 
(Narayanaswamy et al., 2009; Noree et al., 2010). However, al-
though the pace at which novel cytoplasmic structures are being 
identified continues to accelerate, little is known about how spe-
cific enzyme regulatory mechanisms impact the large cytoplasmic 
structures they form.
To assess whether the regulation of enzyme activity controls the 
assembly of such supramolecular structures, we focused our studies 
on a single class of novel intracellular filaments: those formed by 
the Saccharomyces cerevisiae enzyme CTP synthase (Ura7p). URA7 
encodes the major CTP synthase in S. cerevisiae, which catalyzes 
the ATP-dependent transfer of nitrogen from glutamine to UTP, 
generating CTP and glutamate (Figure 1A; Ozier-Kalogeropoulos 
et al., 1991, 1994). The two halves of this reaction require both the 
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Ingerson-Mahar et al., 2010; Liu, 2010; 
Noree et al., 2010). Thus CTP synthase is 
an excellent proving ground for decipher-
ing how classical mechanisms of enzyme 
regulation are connected to the assembly 
of supramolecular structures.
Here we use a structure-guided, site-di-
rected mutagenesis strategy to specifically 
target the major regulatory sites in CTP syn-
thase and assess their role in controlling the 
frequency of CTP synthase filament forma-
tion as well as filament length when altered. 
Mutations that perturb a regulatory loop ad-
jacent to the putative allosteric GTP-binding 
cleft and the ATP-, UTP-, and CTP-binding 
sites stimulate the frequency of filament for-
mation. Given that ATP, UTP, and CTP all 
stabilize the catalytically active tetramer of 
CTP synthase (Pappas et al., 1998), our re-
sults argue that the basic unit of CTP syn-
thase filaments is the inactive dimeric form 
of the enzyme. Our studies of filament 
length demonstrate that there are two pop-
ulations of wild-type CTP synthase filaments: 
very short, “foci-like” structures and long 
filaments. Sites of substrate binding and 
end-product inhibition located on the ami-
doligase domain, as well as allosteric activa-
tion on the glutamine amidotransferase do-
main, are key regulators of filament length. 
A phosphorylation site on the glutamine 
amidotransferase domain also plays a role. 
These data suggest that both domains of 
the protein contribute to polymer structure. 
In contrast, a nonregulatory mutation that 
compromises the glutamine amidotrans-
ferase active site has no effect on CTP syn-
thase filament formation or length. In sum, 
CTP synthase filament formation and structure are intimately con-
nected with the major mechanisms used to regulate enzyme activity, 
but not catalytic function itself.
RESULTS
CTP synthase filaments exhibit a bimodal length 
distribution
Previous analyses reporting the discovery of CTP synthase filament 
formation in yeast, Drosophila, and bacteria described filament 
length of the wild-type enzyme using a qualitative classification 
scheme or as a single parameter such as average length (Figure 1; 
Ingerson-Mahar et al., 2010; Liu, 2010; Noree et al., 2010). A de-
tailed analysis of Ura7p-GFP filaments under our standard growth 
conditions for inducing filament formation—growth to saturation at 
30°C in YPD (2% peptone, 1% yeast extract, 2% dextrose)—revealed 
a bimodal distribution of lengths. The first peak comprised short, 
foci-like structures (<0.75 μm in length; ∼31% of the population), 
and the second peak comprised clearly defined filaments (≥0.75 μm 
in length; ∼69% of the population; Figure 1, E and F). Thus, to pro-
vide the most quantitative assessment of the effects of mutations on 
filament assembly, we carefully measured two aspects of filament 
formation: 1) the frequency, defined as the percentage of cells pos-
sessing Ura7p-GFP filaments, and 2) the length distribution of 
Ura7p-GFP filaments.
C-terminal glutamine amidotransferase (glutamine → glutamate + 
NH3) and the N-terminal amidoligase (ATP + UTP + NH3 → ADP + 
Pi + CTP) domains of the enzyme (Figure 1A).
Ura7p/CTP synthase has several features that make it an ideal 
model system for exploring the functional principles underlying 
intracellular structure formation. First, extensive studies of CTP 
synthase regulation in yeast and other organisms have defined 
multiple ligands that either stimulate (ATP, GTP, and UTP) or in-
hibit (CTP) enzyme activity (Long and Pardee, 1967; Levitzki and 
Koshland, 1972a,b; Aronow and Ullman, 1987; Pappas et al., 
1998; Endrizzi et al., 2005). These nucleotides regulate catalysis 
via three distinct mechanisms that control many enzymes: allos-
teric activation (GTP), tetramerization (ATP, UTP, CTP), and com-
petitive feedback inhibition (CTP) (Long and Pardee, 1967; Levitzki 
and Koshland, 1972a,b; Aronow and Ullman, 1987; Pappas et al., 
1998; Endrizzi et al., 2005). In addition, several phosphorylation 
sites have been identified that also modulate enzyme activity 
(Yang et al., 1996; Yang and Carman, 1996; Park et al., 1999, 
2003; Choi et al., 2003; Choi and Carman, 2007; Chang et al., 
2007). Mutations that disrupt each of these regulatory mecha-
nisms have been identified and characterized (Whelan et al., 
1993; Willemoes et al., 2005; Lunn et al., 2008). Finally, multiple 
prokaryotic and eukaryotic CTP synthases form filaments, arguing 
that this property is evolutionarily conserved (Figure 1, B–D; 
FIGURE 1: CTP synthase reaction, conservation of CTP synthase assembly, and the 
identification of two major populations of CTP synthase structures. (A) CTP synthase reaction. 
(B) Ura7p/CTP synthase structures in S. cerevisiae. (C) CTP synthase staining (green) and actin 
staining (red) in Drosophila melanogaster ovary (Noree et al., 2010). (D) CTP synthase staining 
(green) and Tau staining (red) in rat hippocampal neurons (Noree et al., 2010). (E) Length 
distribution of wild-type (WT) Ura7p-GFP structures of yeast grown for 1 d in YPD. 10 random 
fields from each of six independent experiments were pooled and analyzed (n = 621). Two peaks 
were observed in the length distribution curve with the cutoff value at 0.75 μm. (F) Percentage 
of foci (<0.75 μm) and filaments (≥0.75 μm) for WT Ura7p-GFP structures plotted as bar graphs.
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(Levitzki et al., 1971; Levitzki and Koshland, 
1972a; Pappas et al., 1998). Structural stud-
ies indicate that the dimer and tetramer in-
terfaces are stabilized almost exclusively by 
polar and hydrophobic contacts between 
the amidoligase domains of the component 
monomers (Endrizzi et al., 2004). In the 
Escherichia coli enzyme, a mutation in the 
binding site of the substrate UTP, which lies 
in the amidoligase domain near the tetramer 
interface, has been shown to severely com-
promise UTP binding, tetramer formation 
and catalytic activity (Figure 2B; Lunn et al., 
2008). Strains expressing Ura7p-GFP with 
the equivalent mutation (G148A) expressed 
from the endogenous URA7 locus (see 
Materials and Methods) displayed an 
∼2.7-fold increase in the percentage of cells 
that form filaments as compared with wild 
type (Table 1 and Figure 2C). However, nei-
ther the median length nor the length distri-
bution of the filaments was significantly al-
tered by the G148A mutation (Table 1 and 
Figure 2, C and D). To determine whether 
the enhanced filament formation caused by 
disruption of UTP binding was the conse-
quence of destabilization of the tetramer 
and/or blockade of catalytic activity, we ex-
ploited previous studies that indicated that 
mutation of the active-site cysteine of the 
glutamine amidotransferase domain elimi-
nated enzyme activity (Figure 2B; Paluh 
et al., 1985). We found that a strain express-
ing C404G Ura7p-GFP showed no signifi-
cant difference in the number of cells with 
observable filaments or in filament length 
distribution relative to those expressing wild 
type (Table 1 and Figure 2, C and D). There-
fore, since merely inactivating CTP synthase 
catalytic activity had no effect on filament 
formation, we conclude that the increased 
filament formation of the G148A mutant is 
due to decreased UTP-stimulated tetramer-
ization. These results also argue that Ura7p 
filaments comprise inactive dimers.
Increased catalytic activity is not 
responsible for the block in filament 
formation observed in feedback-
resistant mutants of CTP synthase
Our findings with the UTP-binding-site mu-
tant led us to reexamine the role of CTP-
binding-site mutations in regulating filament assembly. We previ-
ously found that the amidoligase domain mutation, E161K, which 
blocks feedback inhibition of yeast CTP synthase by CTP, abrogates 
the formation of full-length filaments while also causing an increase 
in the formation of foci-like structures (Noree et al., 2010). Given this 
effect, we decided to use our new quantitative definition of foci and 
filaments to examine how this mutation affects the different types of 
structures that can be formed by CTP synthase. Analysis of the 
length distribution of the structures formed by E161K Ura7p-GFP 
revealed that when feedback inhibition is blocked, CTP synthase 
Blocking UTP-mediated tetramerization increases frequency 
of CTP synthase filament formation without altering the 
length distribution
We first examined whether tetramerization of the enzyme plays a 
role in CTP synthase filament formation. In the absence of nucle-
otides, CTP synthase is a catalytically inactive, tightly associated di-
mer (Yang et al., 1994; Pappas et al., 1998). In the presence of ATP, 
UTP, or CTP, two dimers associate to form a tetramer (Figure 2A). 
This oligomerization event is required for proper function of both 
the glutamine amidotransferase- and amidoligase-active sites 
FIGURE 2: Effect of disrupting UTP-mediated tetramerization or the active site of CTP synthase 
on filament formation. (A) The transition of CTP synthase from an inactive dimer to an active 
tetramer is regulated by ATP, UTP, and CTP binding. (B) Crystal structure of E. coli CTP synthase 
(PDB:2AD5; Endrizzi et al., 2005), highlighting residues involved in Mg2+ATP binding/
tetramerization (D72, E140; green), UTP binding/tetramerization (G142; magenta), CTP binding/
tetramerization (E155; orange), GTP binding (R356/G357; cyan), and catalysis (C379; magenta). 
The amidoligase domain (residues 1–266) and glutamine amidotransferase domain (residues 
287–544)/interdomain linker (267–286) are colored light and dark blue, respectively, and the L11 
lid is colored cyan. The bound ADP and CTP molecules in the structure are colored yellow and 
pink, respectively. The numbers in parentheses represent the corresponding amino acids in 
Ura7p. A multiple sequence alignment noting the targeted residues is also provided for 
reference (Supplemental Figure S2). (C) Representative images of yeast strains expressing 
wild-type (WT), catalytic mutant, or tetramerization mutant Ura7p-GFP. The average percentage 
and SEM of cells with Ura7p-GFP structures are indicated below each image. (D) Percentages of 
foci (<0.75 μm) and filaments (≥0.75 μm) for Ura7p-GFP structures are graphed for WT Ura7p-
GFP and each mutant for comparison. Protein levels were uncorrelated with the effects on 
filament frequency or length (Supplemental Table S1 and Supplemental Figure S1).
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due to the extremely low expression level of the E161K Ura7p-GFP. 
This interpretation is inconsistent with our observation that both 
E161K Ura7p-GFP and E161K-C404G Ura7p-GFP formed only foci 
in spite of the fact that the E161K-C404G Ura7p was expressed at 
the normal levels. We also found that when E161K Ura7p-GFP is 
expressed at levels close to endogenous Ura7p-GFP, it forms only 
foci, arguing that expression levels do not contribute to the failure 
of the E161K-Ura7p to form filaments (Noree et al., 2010; Supple-
mental Figure S3).
On the basis of this analysis, we conclude that product binding 
regulates the distribution of CTP synthase between foci and fila-
ments and that this effect is not dependent on competitive inhibi-
tion of catalytic activity or the expression level of the protein. Fur-
ther, the increased propensity of the E161K Ura7p to form foci, like 
that of the G148A mutant to form filaments, suggests that these 
mutations increase structure formation frequency via their common 
ability to inhibit nucleotide-stimulated tetramerization of the amido-
ligase domain.
Mutations in the ATP-binding site of CTP synthase increase 
filament formation
We next investigated the role of the final nucleotide known to mod-
ulate tetramer formation, the substrate ATP. In the crystal structure 
of the ADP/CTP bound form of the E. coli CTP synthase (Endrizzi 
et al., 2005), the carboxylates of D72 and E140 (located in the ami-
doligase domain) chelate a magnesium ion that binds the β-
phosphate of ADP. Hence we predict that mutation of the equiva-
lent residues in Ura7p (D70 and E146) should compromise ATP 
binding and hydrolysis. Strains expressing D70A and E146A Ura7p-
GFP exhibited approximately twofold increase in the number of 
cells containing filaments (Table 1 and Figure 4A). In addition, the 
filament formation is completely disrupted and the enzyme can only 
form foci (Figure 3, A and B). This strongly argues that feedback in-
hibition regulates the distribution of CTP synthase between fila-
ments and foci.
The E161K mutation decreases the affinity of the enzyme for 
CTP, which 1) negatively affects tetramerization (Long and Pardee, 
1967; Pappas et al., 1998) and 2) increases enzyme activity, since 
CTP is a competitive inhibitor of the enzyme (Ostrander et al., 1998). 
This apparently paradoxical behavior is highly dependent upon CTP 
concentration. CTP synthase activity is stimulated by low concentra-
tion of CTP due to increased tetramerization, whereas it is inhibited 
at high concentration due to the overlap of the CTP- and UTP-bind-
ing sites (Long and Pardee, 1967; Pappas et al., 1998). To separate 
these two effects, we once again leveraged the properties of the 
C404G active-site mutation (Figure 3, A and B). If the effects of 
blocking feedback inhibition on filament formation/length are pri-
marily due to an increase in CTP synthase activity, we would predict 
that a Ura7p that is defective for both feedback inhibition and enzy-
matic function would form primarily filaments at the wild-type fre-
quency. Therefore we constructed a strain that expresses Ura7p-GFP 
bearing the feedback resistance mutation, E161K, and the inactivat-
ing C404G mutation. Analysis of the length distributions of E161K-
C404G Ura7p-GFP filaments indicated that the double mutant can 
still only form foci (99% of structures <0.75 μm; Table 1 and 
Figure 3, A and B). The only difference between E161K Ura7p and 
the double mutant was a decrease in the frequency of foci formation 
to a value that was still significantly greater than that of wild type 
(99% for E161K vs. 64% for E161K-C404G). This suggested that 
product binding rather than catalytic activity was the main driver of 
foci formation. However, during our analysis we noted one addi-
tional point of concern: the E161K mutation might cause only foci 
Mutants Description
Cells with 
structures 
(%)
Percentage 
foci
Percentage 
filaments
Average length 
of structures 
(μm)
Median length 
of structures 
(μm)
Number of 
structures 
analyzed
Wild type 26.03 ± 1.72 30.63 ± 3.24 69.37 ± 3.24 1.053 ± 0.039 1.059 620
E161K CTP-binding site 99.86 ± 0.09 98.47 ± 0.59 1.53 ± 0.59 0.363 ± 0.018 0.359 784
E161K-C404G CTP-binding site 
and catalytic site
64.31 ± 4.43 99.41 ± 0.30 0.59 ± 0.30 0.355 ± 0.007 0.347 322
E146A ATP-binding site 56.91 ± 3.98 26.99 ± 3.46 73.01 ± 3.46 1.171 ± 0.027 1.233 431
D70A ATP-binding site 54.69 ± 4.08 36.40 ± 4.24 63.60 ± 4.24 0.893 ± 0.048 0.895 402
R381M GTP-binding site 86.37 ± 2.69 13.90 ± 3.13 86.10 ± 3.13 1.370 ± 0.036 1.407 415
R381P GTP-binding site 81.91 ± 6.61 17.92 ± 1.59 82.08 ± 1.59 1.202 ± 0.022 1.216 388
G382A GTP-binding site 58.16 ± 4.80 46.00 ± 9.86 54.00 ± 9.86 0.828 ± 0.067 0.789 480
C404G Catalytic-site 29.13 ± 2.57 29.11 ± 0.93 70.89 ± 0.93 1.030 ± 0.016 1.043 385
G148A Tetramerization 72.08 ± 9.90 27.80 ± 3.36 72.20 ± 3.36 1.150 ± 0.018 1.179 519
S330A Phosphorylation site 28.18 ± 1.86 39.86 ± 3.50 60.14 ± 3.50 0.905 ± 0.042 0.887 315
S354A Phosphorylation site 27.77 ± 2.70 46.20 ± 2.39 53.80 ± 2.39 0.806 ± 0.027 0.778 431
S424A Phosphorylation site 24.33 ± 3.57 36.50 ± 3.54 63.50 ± 3.54 0.911 ± 0.040 0.887 404
S36A Phosphorylation site 13.90 ± 3.92 36.20 ± 0.16 63.80 ± 0.16 0.913 ± 0.031 0.905 395
S36D Phosphorylation site 6.084 + 1.04 N/A N/A N/A N/A N/A
S36E Phosphorylation site 5.346 ± 1.37 N/A N/A N/A N/A N/A
Percentage of cells with structures was collected by counting 250–300 cells grown for 1 d in YPD and fixed with 3.36% formaldehyde. The experiments were 
repeated five times, and the average ± SEM was calculated. Percentage foci and percentage filaments were obtained by imaging cells grown for 1 d in YPD and 
fixed with 3.36% formaldehyde with the DeltaVision system. Imaging was done for three independent repeats (except for wild type, six repeats). Deconvolved and 
compressed images were analyzed by Fiji, and the structures with length <0.75 μm were defined as foci and those with length ≥0.75 μm as filaments.
TABlE 1: Frequency of CTP synthase assembly, fractions of foci and filaments, average and median lengths of structures, and total number of 
structures used for analysis.
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longer than those formed by wild-type 
Ura7p-GFP. Indeed, the R381M mutation 
caused a 33% increase in median filament 
length, whereas the R381P mutation caused 
a 15% increase (Table 1). Indeed, 86 and 
82% of structures formed by the R381M and 
R381P mutant CTP synthases, respectively, 
were longer than 0.75 μm (both percent-
ages were greater than the 69% of structures 
that are ≥0.75 μm in wild type; Figure 5B).
To further explore the importance of the 
L11 lid in filament formation, we character-
ized a third mutant, G382A, which in L. lactis 
CTP synthase increases the capacity of GTP 
to stimulate glutamine amidotransferase ac-
tivity (Willemoes et al., 2005). Of interest, 
when this mutation was introduced into 
Ura7p, it, like the R381 mutations, caused 
an ∼2.2-fold increase in the number of cells 
with filaments (Figure 5B), however the me-
dian length of the filaments was shortened 
by 25% (Table 1 and Figure 5B). This change 
in median length was also reflected in a shift 
in the distribution of structures from long 
filaments to short foci, with only 54% of the 
structures formed by G382A Ura7p-GFP 
having a length ≥0.75 μm as compared with 
69% of structures formed by wild-type 
Ura7p-GFP. We conclude that the L11 lid 
contributes to regulation of both the fre-
quency of filament formation and filament 
length. Moreover, activating and inactivat-
ing mutations in the allosteric control region 
of CTP synthase have opposing effects on filament length.
Phosphorylation is not a major regulator of CTP synthase 
filament formation
Yeast CTP synthase filament formation is potently stimulated by the 
kinase inhibitor staurosporine (Noree et al., 2010). This suggested to 
us that phosphorylation of CTP synthase might play a direct role in 
regulating filament formation. Previous studies identified four major 
phosphorylation sites in yeast that affect its catalytic activity: Ura7p, 
S36, S330, S354, and S424 (Choi et al., 2003; Park et al., 2003). 
Specifically, phosphorylation at S36, S354, or S424 stimulates Ura7p 
catalytic activity, whereas phosphorylation at S330 inhibits enzyme 
activity (Choi et al., 2003; Park et al., 2003). To determine whether 
any of these phosphorylation sites plays a role in regulating filament 
formation, we generated yeast strains expressing mutant forms of 
Ura7p-GFP in which single phosphorylation sites were inactivated 
by changing the serine in the site to alanine.
The S36A mutation caused an approximately twofold decrease 
in the frequency of filament formation (13.9 vs. 26% for wild type) 
but had little effect on the length of the filaments formed (Figure 6, 
A and B). This result suggested that phosphorylation at S36, in par-
ticular, might be required for efficient filament assembly. To test this 
possibility, we changed S36 to either aspartate or glutamate, two 
amino acid changes that are often used to mimic phosphorylation at 
serine. If phosphorylation of S36 were required for efficient nucle-
ation of filaments, we would expect these mutations to increase the 
frequency of filament formation. However, both the S36D and S36E 
mutations caused approximately fivefold decrease in the frequency 
of filament formation (Table 1). This result suggests that either the 
D70A and E146A mutant filaments were 15% shorter and 16% lon-
ger, respectively, than wild type (Table 1 and Figure 4B). Not only do 
these results further support the role of tetramerization in filament 
formation frequency, they also highlight another region of the ami-
doligase domain involved in filament structure.
The allosteric GTP-binding site regulates both the frequency 
of filament formation and the length of CTP synthase 
filaments
GTP is unique among the four nucleotide regulators of CTP syn-
thase activity in that it is neither a substrate nor a product of CTP 
synthase. Instead, GTP is a positive allosteric regulator that acts to 
increase the rate of catalysis (kcat) of the glutamine hydrolysis reac-
tion (Levitzki and Koshland, 1972b; Willemoes et al., 2005). Multiple 
mutations that alter allosteric regulation of the enzyme have been 
identified in the L11 loop of CTP synthase, a mobile segment of the 
protein adjacent to the allosteric GTP-binding cleft. Based on struc-
tural homology to the small GTP-binding proteins EF-Tu and EF-G, 
as well as other related glutamine amidotransferases, this loop has 
been proposed to form a “lid” that closes over the active site to 
enhance catalysis (Endrizzi et al., 2005). To ask whether the L11 lid 
plays a role in Ura7p filament formation, we first focused on analyz-
ing the effects of two L11 lid mutants, R381M and R381P, which in-
hibit GTP binding and activation of CTP synthase from Lactococcus 
lactis (Figure 5A; Willemoes et al., 2005). Strikingly, yeast strains that 
express either R381M or R381P Ura7p-GFP exhibited an ∼3.1-fold 
increase in the number of cells forming filaments compared with 
strains expressing wild-type Ura7p-GFP (Table 1 and Figure 5B). Fur-
thermore, the filaments formed by both mutants were significantly 
FIGURE 3: Disruption of feedback inhibition blocks CTP synthase filament formation 
independent of catalytic activity. (A) Representative images of yeast strains expressing wild-type 
(WT), CTP-binding mutant, or CTP-binding and catalytic double mutant Ura7p-GFP. Average 
percentage and SEM of cells with Ura7p-GFP structures are indicated below each image. 
(B) Percentages of foci (<0.75 μm) and filaments (≥0.75 μm) for Ura7p-GFP structures are 
graphed for WT Ura7p-GFP and each mutant for comparison.
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in hydrophobic packing (S36A mutation) or 
the introduction of a buried charge (S36D 
and S36E mutations).
In contrast, changing serine S354, S424, 
or S330 to alanine had no effect on the fre-
quency of cells showing filament formation 
(Figure 6A). However, the S354A mutation 
caused a significant shift in the length distri-
bution toward shorter structures, suggest-
ing that S354 might play a role in length 
control (Table 1 and Figure 6B).
DISCUSSION
The discovery of a large number of enzymes 
that assemble into distinct intracellular 
structures in response to specific metabolic 
conditions suggests that the formation of 
these structures is connected to the regula-
tion of their enzyme activity. To address this, 
we used the highly conserved filament-
forming behavior of CTP synthase as a test 
case to determine how enzyme activity is 
connected to filament formation. Yeast CTP 
synthase is activated by GTP-induced allos-
teric changes and ATP/UTP/CTP-induced 
tetramerization and is inhibited by CTP via 
feedback repression (Pappas et al., 1998). 
Phosphorylation has also been found to 
both positively and negatively regulate en-
zyme activity (Choi et al., 2003; Park et al., 
2003). Here we systematically mutated sites 
required for these forms of enzyme regula-
tion to assess their role in controlling CTP synthase polymerization. 
These studies revealed that the regulation of CTP synthase activity 
is tightly coupled to the control of filament formation and/or fila-
ment length. Furthermore, our results argue that CTP synthase fila-
ments comprise an inactive form of the enzyme. Because many en-
zymes that form foci/filaments are regulated by mechanisms similar 
to those that control CTP synthase, our work suggests that the close 
coupling of enzyme activity to filament as-
sembly may be a general feature of this 
class of metabolic enzymes.
Strikingly, our studies found that a muta-
tion in the UTP-binding site that blocks te-
tramerization increases the frequency of fila-
ment formation without altering the length 
distribution of the filaments. Because only 
the tetrameric form of CTP synthase is ac-
tive, this is strong evidence that CTP syn-
thase filaments comprised the inactive form 
of the enzyme. The finding that an active-
site mutation that blocks catalytic activity 
has no effect on filament length or frequency 
suggests that it is not the loss of catalytic 
activity that drives polymerization, but that 
the shift toward dimers is responsible for the 
observed effects. These data are consistent 
with the fact that two mutations engineered 
to cripple binding of ATP (D70A and E146A) 
and hence tetramerization also increase fila-
ment formation but have little effect on fila-
ment length (Figure 7). Although we focused 
S36D and S36E mutations do not properly mimic phosphorylation 
at S36 or that S36 is merely an important residue for initiating fila-
ment formation independent of its phosphorylation state. In the 
E. coli CTP synthase crystal structure (Endrizzi et al., 2004), the 
equivalent residue, I38, is completely buried behind the ATP-bind-
ing site. Therefore it is likely that the S36 mutations are perturbing 
the structure of CTP synthase (and filament formation) via alterations 
FIGURE 4: Mutations in the ATP-binding site of CTP synthase increase filament formation. 
(A) Representative images of yeast strains expressing wild-type (WT), E146A, and D70A 
Ura7p-GFP. Average percentage and SEM of cells with Ura7p-GFP structures are indicated 
below each image. (B) Percentages of foci (<0.75 μm) and filaments (≥0.75 μm) for Ura7p-GFP 
structures are graphed for WT Ura7p-GFP and each mutant for comparison.
FIGURE 5: Effect of mutations in the allosteric regulatory domain on CTP synthase structure 
formation. (A) Representative images of yeast strains expressing wild-type (WT) or GTP-binding-
site mutant Ura7p-GFP. The average percentage and SEM of cells with Ura7p-GFP structures are 
indicated below individual image. (B) Percentages of foci (<0.75 μm) and filaments (>0.75 μm) for 
Ura7p-GFP structures are graphed for WT and each GTP-binding-site mutant for comparison.
2288 | C. Noree, E. Monfort, et al. Molecular Biology of the Cell
frequency of structure formation via effects on tetramer formation. 
Further, like the allosteric L11 lid, this site also plays a critical role in 
controlling filament length/structure.
Of interest, although disruption of tetramerization, allosteric regu-
lation, and feedback inhibition all appear to have strong effects on 
filament formation, only one of the four phosphorylation-site muta-
tions, S354A, had effects on filament assembly that could not be at-
tributable to the likely disruption of the CTP synthase structure. S354 
appears to contribute to the control of filament length, since the 
S354A mutation caused an increase in foci relative to filaments while 
leaving the frequency of filament formation unaltered. Intriguingly, 
this residue is located on a surface loop ∼10–15 Å from the L11 lid on 
the same face of the glutamine amidotransferase domain, further 
suggesting that this domain plays a critical role in filament structure.
In sum, our results argue that the mechanisms that control CTP 
synthase activity, allosteric changes, tetramerization, feedback inhi-
bition, and phosphorylation are also regulators of both the length of 
CTP synthase filaments and number of CTP synthase filaments that 
form. These data would be consistent with a model of a CTP syn-
thase polymer in which inactive dimers of the enzyme interacted via 
the surface of the glutamine amidotransferase domain containing 
the L11 lid and the surface of the amidoligase domain near the CTP-
binding site (Figure 7). Further structural studies will be required to 
confirm this proposal. The regulation of supramolecular complex 
formation in other enzymes may be similarly coupled to the known 
mechanisms for regulating the activity of those enzymes.
One of the most surprising results of our study is the finding that 
Ura7p can form two distinct supramolecular complexes: foci and 
filaments. It is unclear whether these two structures represent two 
distinct regulatory structures or whether foci formation is a critical 
step on the path to assembling a full-length filament. It is worth not-
ing, however, that we observe primarily long filaments in older cul-
tures (overnight to 5 d) and that acute shift to low glucose yields 
structures that are more like foci (unpublished data; Noree et al., 
2010). This suggests that these two structures may be kinetically 
related to foci forming first, followed by maturation into a filament. 
This model is also consistent with the opposite effects of the E161K 
on the simplest model in which dimers polymerize directly due to 
the fact that only dimeric and tetrameric forms of CTP synthase 
exist, it is still possible that the dimers could form a novel oligomer 
before polymerization. Structural studies of the CTP synthase fila-
ment will be necessary to resolve this issue.
Although the model of a CTP synthase filament comprising dim-
ers is an attractive one, our studies of the L11 lid suggest that addi-
tional conformational changes are required for efficient polymeriza-
tion. All of the mutations in the L11 lid that we analyzed increased the 
frequency of filament formation, suggesting that the conformation of 
this domain clearly contributes to the regulation of filament forma-
tion. Both mutations that prevent allosteric regulation by GTP, as well 
as one that causes increased activation by GTP, increase filament as-
sembly. However, they have opposite effects on filament length. Of 
interest, the glutamine analogue 6-diazo-5-oxo-l-norleucine, which 
binds to the glutamine amidotransferase domain, has been found to 
eliminate CTP synthase filaments in E. coli and increase filament for-
mation in Drosophila and human cells (Ingerson-Mahar et al., 2010; 
Carcamo et al., 2011; Chen et al., 2011). Our results, together with 
the previous inhibitor experiments, suggest that there are specific 
conformational changes within the L11 lid and likely other parts of 
the glutamine amidotransferase domain that affect the ability of CTP 
synthase to form either long filaments or short foci.
Another major site for controlling the length distribution of CTP 
synthase filaments is the feedback inhibition site. An E161K muta-
tion blocks CTP binding to CTP synthase, causing a corresponding 
increase in enzyme activity due to the loss of feedback inhibition by 
CTP, as well as a decreased tendency to tetramerize. Our quantita-
tive analysis of this mutation revealed that it completely eliminates 
filament assembly, producing only foci and further causing an in-
crease in the frequency of foci formation. Furthermore, our analysis 
of an Ura7p double mutant that both has lost feedback inhibition 
(E161K) and is catalytically defective (C404G) found that catalytic 
activity is not required for the loss of filament formation, arguing 
that the increase in enzyme activity is not responsible for the block 
in filament assembly. Thus, like the UTP/ATP substrate binding 
sites, the product feedback inhibition site probably increases the 
FIGURE 6: Phosphorylation is not a major regulator of CTP synthase filament. (A) Representative images of yeast 
strains expressing wild-type (WT) Ura7p-GFP or Ura7p-GFP where specific phosphorylation sites are mutated. The 
average percentage and SEM of cells with Ura7p-GFP structures are indicated below each image. (B) Percentages of 
foci (<0.75 μm) and filaments (≥0.75 μm) for Ura7p-GFP structures are graphed for WT and each mutant for comparison.
Volume 25 August 1, 2014 Regulation of CTPS filament formation | 2289 
was then used as a base plasmid for gener-
ating mutations in the URA7 gene by PCR-
based site-directed mutagenesis, which 
were then validated by sequencing.
To introduce URA7::GFP variants into the 
endogenous URA7 locus in yeasts, the mu-
tant plasmids were used as templates to 
PCR amplify a cassette containing coding 
region of ura7::GFP, a copy of HIS3 se-
quence (selectable marker), and a sequence 
homologous to 50 base pairs downstream of the URA7 stop codon 
(required for homologous recombination at the endogenous URA7 
locus). Yeasts were transformed with the purified PCR product of the 
ura7::GFP cassette via the heat shock method (Noree et al., 2010), 
incubated overnight at 30°C, and then replica plated onto histidine-
dropout plates. All yeast mutants were verified by DNA sequencing 
(Eton Bioscience and Retrogen).
Quantitation of URA7-encoded CTP synthase foci/filaments
Wild-type or mutated URA7::GFP strains were grown in 5 ml of YPD 
at 30°C with shaking for 1 d. Cells were fixed by adding 100 μl of 
37% (wt/vol) formaldehyde (Fisher Scientific) to 1 ml of yeast liquid 
culture, incubated on a rotating platform for at least 15 min at room 
temperature, collected by centrifugation at 6000 rpm for 1 min, and 
washed once with sterile water. The cells were then resuspended in 
1 M sorbitol (US Biologicals). A slide was prepared by pipetting a 
few microliters of the cell suspension onto a slide, which was then 
covered by a coverslip and inverted, with some pressure applied on 
the slide to allow excess liquid to be removed from the sample to 
improve imaging.
To determine the percentage of cells containing Ura7p-GFP 
structures, five different areas were selected (∼50 cells/area) for 
counting using a Zeiss Axiovert 200M microscope with a 100× 
Plan-Apochromat 100×/1.40 oil objective lens. The total number of 
cells and the number of cells with Ura7p-GFP structures were de-
termined and reported as a percentage of cells showing Ura7p-
GFP foci/filaments. Experiments were repeated five times for 
graphing and statistical analysis (mean ± SEM).
For analysis of the length distribution of Ura7p-GFP foci and fila-
ments, imaging was performed using a DeltaVision system with an 
Olympus IX70 microscope, Olympus PlanApo 60×/1.40 Oil objec-
tive, and softWoRx software, version 2.5 (Applied Precision). At least 
10 areas on the slide were randomly picked. For each, images in the 
Z-axis were taken every 0.2 μm over ∼1–2 μm. Each was then decon-
volved and compressed into a single image. The processed images 
were then quantified using ImageJ (National Institutes of Health, 
Bethesda, MD). Each image was transformed into 8-bit format, 
adjusted to the threshold with a setting at 30, 255. The foci and 
filaments in each image were computed via the function Analyze 
Particles, excluding structures with size <0.01 μm2. The value of 
the “major axis” of each Ura7p-GFP structure was collected for 
preparing a graphic distribution of Ura7p-GFP foci and filaments 
(∼100–300 structures were analyzed for each mutant). Three inde-
pendent experiments were done for each condition or mutation. 
Statistical analysis was performed using Prism 5 (GraphPad Soft-
ware). One-way analysis of variance was used to test whether there 
was a statistically significant difference between wild type and each 
mutant in the length distribution of Ura7p-GFP structures.
Protein sample preparation and Western blot analysis
Whole-cell extracts were obtained by growing yeast cells in the 
indicated conditions. The cells with OD600 of 2.5 were harvested 
and G148A mutations. Both disrupt nucleotide-stimulated tetramer-
ization and would be predicted to promote filament formation, but 
the E161K mutation forms only foci, whereas the G148A mutation 
promotes filament formation. If foci were a precursor to filaments, 
this would explain why both mutations increase the number of struc-
tures (foci or filaments). This also suggests that the E161 residue is 
necessary for the foci-to-filament transition. The possible existence 
of a precursor structure that matures into a filament would make 
these filaments distinct from classical cytoskeletal filaments and 
might explain why protein expression level is poorly correlated with 
filament assembly (Supplemental Figure S1). In vitro reconstitution 
and structural analysis of both foci and filaments will be necessary to 
firmly establish the relationship between these two structures.
Although we find that there is a close coupling between the 
regulation of enzyme activity and filament assembly, the question of 
why CTP synthase polymerizes remains unanswered. Given that CTP 
synthase is already regulated by feedback repression, allosteric acti-
vation, phosphorylation, and substrate-induced tetramerization, 
adding regulation via polymerization would seem superfluous. The 
fact that CTP synthase polymerizes in growth conditions in which 
nutrients are limiting, such as stationary phase, suggests that fila-
ment formation is used to regulate enzyme activity in response to a 
specific metabolic state. Feedback repression, allosteric activation, 
and substrate-induced tetramerization all respond rapidly to changes 
in metabolite levels. In contrast, a metabolic polymer that has nucle-
ation-limited assembly and end-limited disassembly might be less 
responsive to metabolite levels and allow transient changes in me-
tabolites to be ignored due to the lag in assembly and the fact that 
exiting the polymer will be dependent on the number of filament 
ends. This might be particularly important when cells exit states, 
such as stationary phase, where the cell might not want to activate 
metabolic pathways unless there is a clear, sustained change in the 
energy status of the cell. Given the recent progress in metabolom-
ics, it should be possible to test this proposed role of supramolecu-
lar enzyme structures in regulating metabolic network activity.
MATERIALS AND METHODS
Media and yeast strains
All yeast strains were derived from a parent strain with the genotype 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 (BY4741). Strains with GFP-
tagged genes were from the yeast GFP collection (Howson et al., 
2005). All yeast strains were grown at 30°C in YPD unless otherwise 
indicated.
URA7-GFP plasmids were constructed with standard molecular 
biology techniques. A DNA cassette containing URA7::GFP plus 
501 base pairs upstream of the URA7 start codon was amplified by 
PCR from genomic DNA isolated from yeasts containing URA7::GFP 
(from the yeast GFP collection; Invitrogen) using JW1064 and JW925 
(sequences available on request). This URA7-GFP cassette was 
then subcloned into a pRS403 plasmid (a gift from Randy 
Hampton, University of California, San Diego). The resulting plasmid, 
named JW206 (created by Brian Sato, University of California, Irvine), 
FIGURE 7: Model for CTP synthase filament formation. The transition of CTP synthase from an 
inactive dimer to an active tetramer is regulated by ATP, UTP, and CTP binding. We propose that 
the dimer can also partition into filaments in an inactive state.
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by centrifugation at 6000 rpm for 1 min and resuspended in 100 μl 
of sterile water. Next this suspension was treated with an addi-
tional 100 μl of 0.2 N sodium hydrochloride (Fisher Scientific). 
After a 5-min incubation at room temperature, cells were collected 
by centrifugation at 6000 rpm for 1 min. SDS–PAGE loading buffer 
(with 1× Protease Inhibitor Cocktail; Sigma-Aldrich) was added to 
the cell pellet. After vortexing vigorously and boiling for 5 min, the 
sample was spun down at 10,000 rpm for 1 min and resolved 
by 10% SDS–PAGE. Proteins were transferred to a nitrocellulose 
membrane (BioRad) by electroblotting (Owl HEP-1; Thermo Scien-
tific). Then standard protocol for Western blot was performed. To 
detect GFP-tagged proteins, 1:5000 rabbit anti-GFP (Torrey Pines 
Biolabs) was used as a primary antibody and 1:10,000 ECL donkey 
anti-rabbit immunoglobulin G (IgG), horseradish peroxidase–
linked whole antibody (GE Healthcare UK) as a secondary anti-
body. For internal loading control detection, 1:10,000 mouse anti–
3-phosphoglycerate kinase (yeast) IgG1 monoclonal antibody 
(Invitrogen) was used as a primary antibody and 1:2500 ECL sheep 
anti-mouse IgG, horseradish peroxidase–linked whole antibody 
(GE Healthcare UK) as a secondary antibody. Quantitation of each 
band was done using ImageJ.
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